ARWR
Arrowhead Pharmaceuticals
$82.76
+$0.13 (+0.16%)Sep 10, 2026
Key metrics
The numbers that frame ARWR today
- Market cap
- $11.69B
- P/E (TTM)
- -36.5
- EV / FCF
- -173.2
- Gross margin
- 100%
- EV / Sales
- 19.4
- ROIC
- -8.5%
- Div yield
- 0%
- Debt / equity
- 3.0
- 52wk Low
- $27.80
- 52wk High
- $95.49
Growth
Revenue and earnings trend for ARWR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ARWR
Is Arrowhead Pharmaceuticals a good buy?
Yes. Arrowhead Pharmaceuticals has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks excellent, which supports the long-term business case. We think Arrowhead Pharmaceuticals is selling at a high price, which cuts against the buy case.
What is the market capitalization of ARWR?
Arrowhead Pharmaceuticals's market capitalization is $11.69B.
What is the P/E ratio for ARWR stock?
Arrowhead Pharmaceuticals's current P/E ratio is -36.5.
What is the 52-week high for ARWR stock?
The 52-week high for Arrowhead Pharmaceuticals is $95.49. The current close of $82.76 is 13.3% below that high.
What is the 52-week low for ARWR stock?
The 52-week low for Arrowhead Pharmaceuticals is $27.80. The current close of $82.76 is 197.7% above that low.
Does ARWR stock pay dividends?
Arrowhead Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ARWR?
Arrowhead Pharmaceuticals's Debt / Equity ratio is 2.96.